Hyloris Pharmaceuticals has a registered holding activity and consists mainly of financial fixed assets; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €87.2m and a net result of -€1.2m. Equity is growing by about 9.7% per year across the filed financial years. Its solvency ranks better than 84% of 1,151 sector peers (NACE 82, financial year 2025). The company has been active since 2017 and the Belgian Official Gazette contains no insolvency or warning signals.
NACE 82990Activities of holding companies NACE 64210
2nd largest company by equity in the province of Liège, Administrative and support services sector1 site
Size
€3.8mturnover 2025
Staff
3.4 FTE
Equity
€87.2m
Loss
-€1.2m
Standalone figures, without subsidiaries
Financial health
Holding: outside the score modelBankruptcy probability: sector outside the model
Structure
Board
11 members
Holdings
5
SVR ManagementDaily manager · permanent representative Stijn VAN ROMPAY
Auditor: BDO BEDRIJFSREVISOREN-BDO REVISEURS D'ENTREPRISESAccounts 24 days early
SignalsneutralLatest accounts filed on timeShow the evidence
Checked score
Outside the general model
Checked score
A figure from 0 to 100: the higher it is, the smaller the chance that the company goes bankrupt within twelve months. The band, from Critical to Excellent, follows from that chance; within the band, how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
Holding: general score not applicable
The company has a registered holding activity and financial fixed assets account for more than half of its assets. The general operating-company model is unsuitable for this profile, so we show no financial axes either. Filed figures remain available.
Bankruptcy probability, 12 months
Bankruptcy probability
The chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. 0.2% means about 2 in 1,000 comparable companies. The higher it is, the shorter the payment term to agree.
This is a financial institution (bank, insurer or financial holding). A bank balance sheet works differently from that of an ordinary trading or manufacturing company. We therefore show no bankruptcy probability rather than a misleading figure.
tick = median of all Belgian filingsring = median in the sector
This company filed its last 5 accounts on average 2 days after the deadline; the sector median (NACE 82) for financial year 2024 is 7 days before the deadline, and 35% of those companies filed late.
Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 July (4 of the last 5 filed years within 30 days of that day).